Product Information
VANDAZOLE VAGINAL 0.75% GEL is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $0.3342 per GM under NDC 00245086070. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 20, 2005. Its Orange Book therapeutic-equivalence code is BX.
Strength
7.5 mg/g
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245086070
Classification
Brand
Dosage Form
GEL
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
METRONIDAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA021806FDA Approved
5/20/2005
TE Code
BX
On Market Since
10/4/2005
Pharmacological Classes
Price Statistics
The NADAC for VANDAZOLE VAGINAL 0.75% GEL has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 19.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3342 per GM |
|---|---|
| All-time high | $1.3217 (Mar 16, 2016) |
| All-time low | $0.2316 (Nov 19, 2014) |
| 52-week high | $0.5647 |
| 52-week low | $0.3235 |
| Median price | $0.7974 |
| Average price | $0.7381 |
| Largest weekly change | +371.1% (May 20, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metronidazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nitroimidazole Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VANDAZOLE VAGINAL 0.75% GEL?
The current National Average Drug Acquisition Cost (NADAC) for VANDAZOLE VAGINAL 0.75% GEL, manufactured by Upsher-Smith Laboratories LLC, is $0.3342 per GM (NDC 00245086070), effective Sep 30, 2026.
How has the price of VANDAZOLE VAGINAL 0.75% GEL changed over time?
Over the history we have for it, the NADAC for VANDAZOLE VAGINAL 0.75% GEL has risen 19.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VANDAZOLE VAGINAL 0.75% GEL?
Since Nov 28, 2013, the NADAC for VANDAZOLE VAGINAL 0.75% GEL has ranged from a low of $0.2316 (Nov 19, 2014) to a high of $1.3217 (Mar 16, 2016), with a median of $0.7974 per GM.
Are there cheaper alternatives to VANDAZOLE VAGINAL 0.75% GEL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METRONIDAZOLE VAGINAL 0.75% GL, is $0.1406 per GM — about 58% below VANDAZOLE VAGINAL 0.75% GEL.
Who manufactures VANDAZOLE VAGINAL 0.75% GEL?
VANDAZOLE VAGINAL 0.75% GEL (NDC 00245086070) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.